The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Abstract
We describe a case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination. This was particularly evident for the C9neo antigen, which is a marker for the activated lytic complement complex and was exclusively deposited in the areas of active myelin destruction. In addition, macrophages in the lesions contained degradation products that were immunoreactive for myelin antigens, immunoglobulins, and C9neo antigen. Destruction of myelin sheaths was associated with incomplete loss of oligodendrocytes in the active areas and reappearance of oligodendrocytes with remyelination in the inactive plaque center.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Self-citationMonocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Self-citationBrunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J., & Linington, C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10930.x · Cited by 409
Self-citationPatterns of oligodendroglia pathology in multiple sclerosis
Ozawa, K., Suchanek, G., Breitschopf, H., Br€ck, W., Budka, H., Jellinger, K., & Lassmann, H. (1994) · Brain · doi:10.1093/brain/117.6.1311 · Cited by 404
Self-citationT and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
Sun, J., Link, H., Olsson, T., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315
Piddlesden, S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 287
Self-citationSelmaj, K., Brosnan, C. F., & Raine, C. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6452 · Cited by 283
Gold, R., Schmied, M., Rothe, G., Zischler, H., Breitschopf, H., Wekerle, H., & Lassmann, H. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.7.8515045 · Cited by 270
Self-citationMultiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
Prineas, J. W., & Graham, J. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100205 · Cited by 264
BLOOD-BRAIN BARRIER DAMAGE IN ACUTE MULTIPLE SCLEROSIS PLAQUES: AN IMMUNOCYTOLOGICAL STUDY
GAY, D., & ESIRI, M. (1991) · Brain · doi:10.1093/brain/114.1.557 · Cited by 239
Breitschopf, H., Suchanek, G., Gould, R., Colman, D., & Lassmann, H. (1992) · Acta Neuropathologica · doi:10.1007/bf00227734 · Cited by 235
Self-citationZwadlo, G., Bröcker, E. B., von Bassewitz, D. B., Feige, U., & Sorg, C. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1487 · Cited by 234
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis
Vass, K., Lassmann, H., Wekerle, H., & Wisniewski, H. M. (1986) · Acta Neuropathologica · doi:10.1007/bf00691433 · Cited by 213
Self-citationZwadlo, G., Schlegel, R., & Sorg, C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.2.512 · Cited by 195
Bhardwaj, R. S., Zotz, C., Roth, J., Goebeler, M., Mahnke, K., Falk, M., Meinardus‐Hager, G., Sorg, C., & Zwadlo‐Klarwasser, G. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220732 · Cited by 185
IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS
COMPSTON, D. A. S., MORGAN, B. P., CAMPBELL, A. K., WILKINS, P., COLE, G., THOMAS, N. D., & JASANI, B. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01231.x · Cited by 185
Induction of stress protein HSP70 in nerve cells after status epilepticus in the rat
Vass, K., Berger, M. L., Nowak, T. S., Welch, W. J., & Lassmann, H. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90695-2 · Cited by 178
Self-citationThe immunogenesis of the multiple sclerosis plaque
Lumsden, C. E. (1971) · Brain Research · doi:10.1016/0006-8993(71)90052-7 · Cited by 170
Radzun, H., Hansmann, M. L., Heidebrecht, H. J., Bödewadt-Radzun, S., Wacker, H. H., Kreipe, H. H., Lumbeck, H., Hernandez, C., Kuhn, C., & Parwaresch, M. R. (1991) · PubMed · Cited by 148
Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137
Self-citationNormal rat serum cytotoxicity against syngeneic oligodendrocytes
Scolding, N. J., Morgan, B. P., Houston, A., Campbell, A. K., Linington, C., & Compston, D. A. S. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90030-0 · Cited by 100
Vitronectin and Integrin Vitronectin Receptor Localization in Multiple Sclerosis Lesions
Sobel, R. A., Chen, M., Maeda, A., & Hinojoza, J. R. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00007 · Cited by 73
Immunofluorescence study of brain plaques from two patients with multiple sclerosis
Woyciechowska, J., & Brzosko, W. (1977) · Neurology · doi:10.1212/wnl.27.7.620 · Cited by 57
Grundke, I., & Bornstein, M. B. (1980) · Neurology · doi:10.1212/wnl.30.7.749 · Cited by 55
Matthieu, J., & Amiguet, P. (1990) · Developmental Neuroscience · doi:10.1159/000111858 · Cited by 54
Zajicek, J., Wing, M. G., Skepper, J. N., & Compston, A. (1995) · PubMed · Cited by 50
Rodriguez, M., Prayoonwiwat, N., Howe, C. L., & Sanborn, K. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199403000-00004 · Cited by 42
Wu, E., Brosnan, C. F., & Raine, C. S. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199303000-00005 · Cited by 31
Cited by
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
Metadata
- Authors
- Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 43
- Issue
- 4
- Pages
- 465-471
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2137350492
- Cited by
- 422
- References
- 29
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.